Patient Guide: Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 14 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06668558
Status: 🟢 Enrolling Now
Condition: Acute Myeloid Leukemia
Phase: PHASE2

Where You Can Participate

This study is available at 14 locations across the country.

Top locations include:
  • • Palma de Mallorca, Balearic Islands
  • • Palma de Mallorca, Balearic Islands
  • • Badalona, Catalonia
  • • And 11 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia - Join Clinical Trial NCTNCT06668558

How to Join This Clinical Trial - NCTNCT06668558

Learn how to participate in this PHASE2 trial studying an investigational therapy for Acute Myeloid Leukemia. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Acute Myeloid Leukemia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Acute Myeloid Leukemia
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06668558 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 14 locations. Find a study site near you:

Clinical Research Site

Palma de Mallorca, Balearic Islands 07120 - Spain

Status: RECRUITING

Clinical Research Site

Palma de Mallorca, Balearic Islands 07198 - Spain

Status: RECRUITING

Clinical Research Site

Badalona, Catalonia 08916 - Spain

Status: RECRUITING

Clinical Research Site

Barcelona, Catalonia 08003 - Spain

Status: RECRUITING

Clinical Research Site

Barcelona, Catalonia 08025 - Spain

Status: RECRUITING

Clinical Research Site

Barcelona, Catalonia 08035 - Spain

Status: RECRUITING

Clinical Research Site

Barcelona, Catalonia 08036 - Spain

Status: RECRUITING

Clinical Research Site

Girona, Catalonia 17007 - Spain

Status: RECRUITING

Clinical Research Site

L'Hospitalet de Llobregat, Catalonia 08908 - Spain

Status: RECRUITING

Clinical Research Site

Lleida, Catalonia 25196 - Spain

Status: RECRUITING

And 4 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Acute Myeloid Leukemia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships